PortfoliosLab logoPortfoliosLab logo
IDNA vs. WDNA
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IDNA vs. WDNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and WisdomTree BioRevolution Fund (WDNA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IDNA achieves a 17.72% return, which is significantly higher than WDNA's 12.77% return.


IDNA

1D
0.46%
1M
4.69%
YTD
17.72%
6M
14.99%
1Y
51.77%
3Y*
10.60%
5Y*
-8.07%
10Y*

WDNA

1D
0.90%
1M
8.40%
YTD
12.77%
6M
10.12%
1Y
49.11%
3Y*
5.29%
5Y*
-4.94%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

IDNA vs. WDNA - Yearly Performance Comparison


2026 (YTD)20252024202320222021
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
17.72%17.26%-0.72%-7.63%-42.28%-5.50%
WDNA
WisdomTree BioRevolution Fund
12.77%22.68%-14.18%-2.07%-26.29%-4.92%

Correlation

The correlation between IDNA and WDNA is 0.89, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.89

Correlation (3Y)
Calculated over the trailing 3-year period

0.89

Correlation (5Y)
Calculated over the trailing 5-year period

0.91

Correlation (All Time)
Calculated using the full available price history since Jun 3, 2021

0.90

The correlation between IDNA and WDNA has been stable across timeframes, ranging from 0.89 to 0.91 - a consistent structural relationship.

IDNA vs. WDNA - Sectors Allocation Comparison


Sectors
IDNA
WDNA

Healthcare

99.3%
85.0%

Industrials

0.3%

-

Basic Materials

-

6.5%

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

3.0%

Energy

-

1.1%

Financial Services

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

IDNA
99.3%
WDNA
85.0%

Industrials

IDNA
0.3%
WDNA

-

Basic Materials

IDNA

-

WDNA
6.5%

Communication Services

IDNA

-

WDNA

-

Consumer Cyclical

IDNA

-

WDNA

-

Consumer Defensive

IDNA

-

WDNA
3.0%

Energy

IDNA

-

WDNA
1.1%

Financial Services

IDNA

-

WDNA

-

Real Estate

IDNA

-

WDNA

-

Technology

IDNA

-

WDNA

-

Utilities

IDNA

-

WDNA

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IDNA vs. WDNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDNA
IDNA Risk / Return Rank: 7070
Overall Rank
IDNA Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
IDNA Sortino Ratio Rank: 6666
Sortino Ratio Rank
IDNA Omega Ratio Rank: 5555
Omega Ratio Rank
IDNA Calmar Ratio Rank: 8888
Calmar Ratio Rank
IDNA Martin Ratio Rank: 7474
Martin Ratio Rank

WDNA
WDNA Risk / Return Rank: 6161
Overall Rank
WDNA Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
WDNA Sortino Ratio Rank: 6060
Sortino Ratio Rank
WDNA Omega Ratio Rank: 5151
Omega Ratio Rank
WDNA Calmar Ratio Rank: 8282
Calmar Ratio Rank
WDNA Martin Ratio Rank: 5656
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IDNA vs. WDNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and WisdomTree BioRevolution Fund (WDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IDNAWDNADifference
Sharpe ratioReturn per unit of total volatility

+0.18

Sortino ratioReturn per unit of downside risk

+0.18

Omega ratioGain probability vs. loss probability

1.33

1.31

+0.02

Calmar ratioReturn relative to maximum drawdown

4.88

4.22

+0.66

Martin ratioReturn relative to average drawdown

13.60

9.45

+4.15

IDNA vs. WDNA - Sharpe Ratio Comparison

The current IDNA Sharpe Ratio is 2.09, which is comparable to the WDNA Sharpe Ratio of 1.91. The chart below compares the historical Sharpe Ratios of IDNA and WDNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IDNA vs. WDNA - Drawdown Comparison

The maximum IDNA drawdown since its inception was -68.26%, which is greater than WDNA's maximum drawdown of -58.87%. Use the drawdown chart below to compare losses from any high point for IDNA and WDNA.


Loading charts...

Drawdown Indicators


IDNAWDNADifference

Max Drawdown

Largest peak-to-trough decline

-68.26%

-58.87%

-9.39%

Max Drawdown (1Y)

Largest decline over 1 year

-10.66%

-11.70%

+1.04%

Max Drawdown (3Y)

Largest decline over 3 years

-29.46%

-38.25%

+8.79%

Max Drawdown (5Y)

Largest decline over 5 years

-68.26%

-58.87%

-9.39%

Current Drawdown

Current decline from peak

-41.96%

-27.41%

-14.55%

Average Drawdown

Average peak-to-trough decline

-36.28%

-35.57%

-0.71%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.82%

5.21%

-1.39%

Volatility

IDNA vs. WDNA - Volatility Comparison

iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and WisdomTree BioRevolution Fund (WDNA) have volatilities of 7.25% and 7.42%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IDNAWDNADifference

Volatility (1M)

Calculated over the trailing 1-month period

7.25%

7.42%

-0.17%

Volatility (6M)

Calculated over the trailing 6-month period

18.40%

16.98%

+1.42%

Volatility (1Y)

Calculated over the trailing 1-year period

24.97%

25.95%

-0.98%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.46%

25.14%

+3.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.52%

25.07%

+4.45%

IDNA vs. WDNA - Expense Ratio Comparison

IDNA has a 0.47% expense ratio, which is higher than WDNA's 0.45% expense ratio.


Dividends

IDNA vs. WDNA - Dividend Comparison

IDNA's dividend yield for the trailing twelve months is around 0.91%, less than WDNA's 4.05% yield.


PositionTTM2025202420232022202120202019
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
0.91%1.18%0.98%1.04%0.54%0.70%0.26%0.80%
WDNA
WisdomTree BioRevolution Fund
4.05%4.57%0.75%0.80%0.38%0.10%0.00%0.00%

Frequently Asked Questions


IDNA and WDNA have a correlation of 0.89, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

WDNA has higher volatility (7.42%) compared to IDNA (7.25%). In terms of maximum drawdown, IDNA dropped -68.26% vs WDNA's -58.87%.

On 5-year performance, WDNA leads with -4.94% vs -8.07% for IDNA. On fees, WDNA is cheaper at 0.45% per year. On volatility, IDNA has been the lower-risk option at 7.25%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, WDNA has performed better with a -4.94% return vs -8.07%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

WDNA is cheaper with a 0.45% expense ratio, compared with 0.47% for IDNA.

WDNA has the higher dividend yield at 4.05%, compared with 0.91% for IDNA.

IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index, while WDNA tracks WisdomTree BioRevolution Index. They also come from different issuers: iShares and WisdomTree. Their fees differ too: 0.47% for IDNA and 0.45% for WDNA.

IDNA currently has the higher Sharpe Ratio (2.09 vs 1.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IDNA and WDNA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer